NYSEARCA:OILX

UBS ETRACS S&P GSCI Crude Oil Total Return Index ETN Stock Forecast, Price & News

$5.77
0.00 (0.00 %)
(As of 04/30/2020)
Add
Compare
Today's Range
$5.77
$5.79
50-Day Range
$5.77
$5.77
52-Week Range
$4.36
$37.98
Volume216,530 shs
Average Volume118,480 shs
Market Capitalization$23.21 million
P/E RatioN/A
Dividend Yield0.00%
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive OILX News and Ratings via Email

Sign-up to receive the latest news and ratings for UBS ETRACS S&P GSCI Crude Oil Total Return Index ETN and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer UBS
Fund NameETRACS S&P GSCI Crude Oil Total Return Index ETN
Tax ClassificationExchange-Traded Note
SymbolNYSEARCA:OILX
Inception Date2/17/2016
Fund Manager
WebN/A
PhoneN/A

Fund Focus

Asset ClassCommodities
BenchmarkS&P GSCI Crude Oil Total Return Index
CategoryEnergy
FocusCrude Oil
Development LevelBlended Development
RegionGlobal

Fund Statistics

Assets Under Management$23.27 million
Average Daily Volume$417,766.90
Discount/Premium-0.02%

ETF Expenses

Management Fee0.00%
Other Expenses0.00%
Total Expenses0.00%
Fee Waiver0.00%
Net Expenses0.75%

Administrator, Advisor and Custodian

Administrator
Advisor
Custodian
Distributor
Transfer Agent
Trustee
Lead Market MakerVirtu Financial

speech bubbles
speech bubbles











UBS ETRACS S&P GSCI Crude Oil Total Return Index ETN (NYSEARCA:OILX) Frequently Asked Questions

What stocks does MarketBeat like better than UBS ETRACS S&P GSCI Crude Oil Total Return Index ETN?

Wall Street analysts have given UBS ETRACS S&P GSCI Crude Oil Total Return Index ETN a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but UBS ETRACS S&P GSCI Crude Oil Total Return Index ETN wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has UBS ETRACS S&P GSCI Crude Oil Total Return Index ETN's stock price been impacted by Coronavirus?

UBS ETRACS S&P GSCI Crude Oil Total Return Index ETN's stock was trading at $19.63 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, OILX shares have decreased by 70.6% and is now trading at $5.77.
View which stocks have been most impacted by COVID-19
.

Who are some of UBS ETRACS S&P GSCI Crude Oil Total Return Index ETN's key competitors?

What other stocks do shareholders of UBS ETRACS S&P GSCI Crude Oil Total Return Index ETN own?

Based on aggregate information from My MarketBeat watchlists, some companies that other UBS ETRACS S&P GSCI Crude Oil Total Return Index ETN investors own include Amarin (AMRN), Aduro Biotech (ADRO), (ALT), Armata Pharmaceuticals (ARMP), CRISPR Therapeutics (CRSP), Nabriva Therapeutics (NBRV), Occidental Petroleum (OXY), VBI Vaccines (VBIV), Vaxart (VXRT) and Micron Technology (MU).

What is UBS ETRACS S&P GSCI Crude Oil Total Return Index ETN's stock symbol?

UBS ETRACS S&P GSCI Crude Oil Total Return Index ETN trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "OILX."

How do I buy shares of UBS ETRACS S&P GSCI Crude Oil Total Return Index ETN?

Shares of OILX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is UBS ETRACS S&P GSCI Crude Oil Total Return Index ETN's stock price today?

One share of OILX stock can currently be purchased for approximately $5.77.

How much money does UBS ETRACS S&P GSCI Crude Oil Total Return Index ETN make?

UBS ETRACS S&P GSCI Crude Oil Total Return Index ETN has a market capitalization of $23.21 million.


This page was last updated on 9/21/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.